). Two of these 78 dogs had concurrent adrenal lesions.
In the remaining dogs (44/122; 36%), the pituitary gland was not enlarged. In the dexamethasone-resistant group (79/201), the pituitary gland was enlarged in 47 dogs (59%; median P/B, 0.57 × 10 −2 ; range, 0.32-1.50 × 10 −2 mm −1 ). Eight of these 47 dogs (17%) had concurrent adrenal lesions. In the remaining 32 dexamethasone-resistant dogs (41%), the pituitary gland was not enlarged. Among them, 27 dogs had adrenal lesions and suppressed ACTH concentrations consistent with adrenal-dependent hypercortisolism and 5 dogs were diagnosed with pituitary-dependent hypercortisolism.
Conclusions and Clinical Importance: Concurrent pituitary and adrenal lesions were present in 5% of all dogs with hypercortisolism and in 10% of the dexamethasone-resistant dogs. Diagnostic imaging of both pituitary and adrenal glands should be included in the diagnostic evaluation of every dog with spontaneous hypercortisolism to obtain information needed for estimation of prognosis and choosing the optimal treatment.
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| INTRODUCTION
Spontaneous hypercortisolism or Cushing's syndrome is 1 of the most common endocrine disorders in dogs. 1 The biochemical diagnosis depends on the demonstration of increased cortisol production or decreased sensitivity to glucocorticoid feedback. The endocrine tests of choice are the low-dose dexamethasone suppression test (LDDST) and determination of the urinary corticoid-to-creatinine ratio (UCCR), preferentially combined with a high-dose dexamethasone suppression test (HDDST). 2 In approximately 80%-85% of affected dogs, spontaneous hypercortisolism is pituitary-dependent hypercortisolism (PDH).
In these dogs, a corticotroph adenoma secretes inappropriate and unregulated amounts of ACTH. The remaining 15% of cases of spontaneous hypercortisolism are adrenal-dependent hypercortisolism (ADH). The ACTH-independent hypersecretion of cortisol in these dogs is caused by an adrenocortical adenoma or carcinoma. 1, 3 Differentiating between PDH and ADH is important, because the optimal treatment may be quite different. Pituitary-dependent hypercortisolism can be managed medically (ie, with trilostane or mitotane), but this approach does not limit growth of the pituitary tumor (PT). 3 Hypophysectomy is therefore the treatment of choice, especially in relatively young dogs with an enlarged pituitary gland that may lead to compression of the brain. 4, 5 Alternatively, radiotherapy can be used. 6, 7 In dogs with ADH, adrenalectomy is the best treatment option, particularly because of potential malignancy. [8] [9] [10] To differentiate between PDH and ADH, suppression tests (ie, LDDST or HDDST), measurement of plasma ACTH concentration and diagnostic imaging can be used. In all dogs included in the study, the diagnosis of hypercortisolism was confirmed by an endocrine function test, that is, LDDST or UCCR combined with PO HDDST. Both tests were performed and interpreted as described previously. 2, 21 Blood samples for cortisol (LDDST) and ACTH measurements were collected from the jugular vein and transferred to heparin-coated tubes and ice-chilled EDTA-coated tubes, respectively. Urine samples for UCCR determination were collected by the owner at home, at least 2 days after a veterinary consultation or other potentially stressful event. 13 The plasma cortisol concentrations, plasma ACTH concentrations, and UCCRs were determined as described previously. 13, 22, 23 In Subsequently, post-contrast CT scanning from the liver to the caudal aspect of the left kidney was performed. On cross-sectional images, the structure, shape, and symmetry of both adrenal glands were evaluated. [27] [28] [29] The dorsoventral thickness of the cranial and caudal poles of both adrenal glands was measured, and invasion into blood vessels was determined. The adrenal gland was considered enlarged if the maximum thickness was >7 mm. 14, 30 Bilateral normalsized or symmetrically enlarged adrenal glands with a normal peanutshape and contrast uptake, normal corticomedullary distinction, and no invasion into blood vessels were considered consistent with adrenocortical hyperplasia secondary to PDH. Abnormal adrenal gland shape with heterogeneous contrast uptake in combination with increased adrenal thickness (>7 mm), invasion into bloods vessels, or both were considered consistent with an adrenal lesion suggestive of AT. [31] [32] [33] In these cases, CT scanning was expanded to the thorax to search for visible metastases.
| MATERIALS AND METHODS

| Animals and tests
| Histopathology
Histopathological evaluation of the pituitary and adrenal gland tumors was performed as described previously.
34,35
| Data analysis
Descriptive statistical analysis was performed using commercial statistical software (SPSS 13.1 for Windows, SPSS). The Q-Q plots and the Shapiro-Wilk W-test were used to assess the normality of the data.
Results are expressed as median and range.
| RESULTS
Criteria for inclusion in the study were met by 201 dogs. ; Figure 2A ), the right adrenal gland was asymmetrically enlarged (cranial pole, 14 mm; caudal pole, 7 mm thickness) with heterogeneous contrast uptake ( Figure 2B ).
In this dog, the left adrenal gland was within normal limits (thickness, ; suppressible: cortisol concentration <50% compared to the basal concentration after IV administration of 0.01 mg/kg dexamethasone in the low-dose dexamethasone suppression test (LDDST) or urinary corticoid-to-creatinine ratio (UCCR) <50% of the basal UCCR after PO administration of 0.1 mg/kg dexamethasone (high-dose dexamethasone suppression test, HDDST) 
| DISCUSSION
Our study indicates the importance of advanced diagnostic imaging of the pituitary and adrenal glands in dogs with hypercortisolism to determine prognosis and choose the most optimal treatment option.
Although in dexamethasone-resistant PDH pituitary enlargement is rather common, in our study 64% (78/122) of dogs with dexamethasone-suppressible PDH also had an enlarged pituitary gland. Ideally, the treatment in dogs with an enlarged pituitary gland is removal of the ACTH-producing adenoma by hypophysectomy. 26 Otherwise, substantial enlargement of the pituitary gland may cause pressure on the brain, which could lead to neurological signs associated with the intracranial mass. 5, 36 Hypophysectomy, however, is available only at a few specialty centers, and most dogs with PDH are treated medically with trilostane. 3 The relatively large percentage of dogs with an enlarged pituitary gland in our study indicates that CT imaging of the pituitary area may provide additional information on the prognosis and quality of life of dogs with hypercortisolism. Therefore, advanced diagnostic imaging is indicated not only in dogs treated by surgery but also before starting medical treatment.
In the dogs with dexamethasone-resistant hypercortisolism in our study, 44% (35/79) had adrenal lesions for which CT scan characteristics were suggestive of AT. Twenty-seven of these dogs were diagnosed with ADH, and in 8 dogs pituitary enlargement also was present. These 8 dogs presumably had concurrent pituitary and adrenal hypercortisolism, but the differentiation between a hormonally pole, 7 mm thickness) with heterogeneous contrast uptake (B) and the left adrenal gland (arrow) was within normal limits (7 mm thickness; C) VAN BOKHORST ET AL.
active tumor and other pathology such as hyperplasia or a nonsecreting tumor could not be made. 37 Finding nonfunctional lesions is of 
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Computed tomographic imaging of the adrenal glands is a sensitive way of assessing adrenal structure, but the accuracy of adrenal gland size measurements remains unclear. 27 In CT investigations of the adrenal glands, risk of miscalculation exists when the long axis of the measured adrenal gland is not perpendicular to the transverse view. This situation might be compensated by CT quantification of adrenal gland volume and attenuation, but the advantage of this method needs further validation in a patient population. 28, 29 For the purpose of our study, the structure and symmetry of the adrenal glands were of main interest and the only cutoff used was a >7 mm thickness for an enlarged adrenal gland, measured from the crosssectional CT image. The 7 mm threshold has been adapted from studies on ultrasonographic evaluation of canine adrenal glands. 14, 15 However, concordance between adrenal gland measurements on CT imaging and ultrasonography has not yet been assessed. Another limitation of our study is that the ACTH assay used has not been validated to discriminate between PDH and ADH. The applied cutoff value of 40 ng/L has been adapted from previous studies, but misclassification in some cases is possible.
The majority of dogs diagnosed with ADH in our study underwent adrenalectomy and histopathology of the adrenal glands confirmed an adrenocortical adenoma or carcinoma. 34 In the remaining dogs with ADH, another therapeutic intervention was chosen and adrenal histopathology was not available. In these dogs, the diagnosis of AT was supported by structural features, shape, asymmetry, attenuation, and excessive size of the adrenal gland. The differentiation between cortisol-secreting AT and pheochromocytoma, aldosteronoma, a metastatic mass, or a nonfunctional AT cannot be made by diagnostic imaging. 31, 33 In the dogs included in our study, the presumptive diagnosis was hypercortisolism and, because there was no clinical suspicion of other adrenal pathology, no additional endocrine testing or fine-needle aspiration biopsies were performed. Still, lack of adrenal histopathology in some of the dogs is a major limitation of this study.
The differentiation between bilateral adrenal hyperplasia and bilateral ATs is difficult. 17, 41 Such was the case in the 2 dogs in our study with dexamethasone-suppressible hypercortisolism and adrenal lesions. Although in the 1 dog, in which no histopathology of the adrenal glands was available, the nature of the adrenal mass remains unknown, in the other dog, an adrenocortical carcinoma was confirmed. In general, dogs with PDH develop symmetrical bilateral adrenocortical hyperplasia. 16, 17 However, some have adrenocortical nodular hyperplasia, in which 1 or both adrenal glands can have 1 or many variably sized nodules. With time, it may be difficult to distinguish between adrenal nodular hyperplasia and AT. It might even be hypothesized whether they occur independently of each other or the AT transitioned from initial hyperplasia. 42 In the total group of dogs with hypercortisolism in our study, 82%
(164/201) were diagnosed with PDH and 13% (27/201) with ADH.
The dogs in our study were referred and therefore some selection might have occurred compared to dogs with hypercortisolism presented to first opinion practices, but the percentages of PDH and ADH in our study group resemble the percentages reported in the veterinary literature. 
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